Preclinical and clinical evidence suggests pro-inflammatory cytokines might play an important role in the neurobiology of schizophrenia and stress-related psychiatric disorders. Interleukin-18 (IL-18) is a member of the IL-1 family of cytokines and it is widely expressed in brain regions involved in emotional regulation. Since IL-18 involvement in the neurobiology of mental illnesses, including schizophrenia, remains unknown, this work aimed at investigating the behavior of IL-18 null mice (KO) in different preclinical models: 1. the prepulse inhibition test (PPI), which provides an operational measure of sensorimotor gating and schizophrenic-like phenotypes; 2. amphetamine-induced hyperlocomotion, a model predictive of antipsychotic activity; 3. residentintruder test, a model predictive of aggressive behavior. Furthermore, the animals were submitted to models used to assess depressive-and anxiety-like behavior. IL-18KO mice showed impaired baseline PPI response, which was attenuated by D-amphetamine at a dose that did not modify PPI response in wild-type (WT) mice, suggesting a hypodopaminergic prefrontal cortex function in those mice. D-Amphetamine, however, induced hyperlocomotion in IL-18KO mice compared to their WT counterparts, suggesting hyperdopaminergic activity in the midbrain. Moreover, IL-18KO mice presented increased basal levels of IL-1β levels in the hippocampus and TNF-α in the prefrontal cortex, suggesting an overcompensation of IL-18 absence by increased levels of other proinflammatory cytokines. Although no alteration was observed in the forced swimming or in the elevated plus maze tests in naïve IL-18KO mice, these mice presented anxiogenic-like behavior after exposure to repeated forced swimming stress. In conclusion, deletion of the IL-18 gene resembled features similar to symptoms observed in schizophrenia (positive and cognitive symptoms, aggressive behavior), in addition to increased susceptibility to stress. The IL-18KO model, therefore, could provide new insights into how changes in brain immunological homeostasis induce behavioral changes related to psychiatric disorders, such as schizophrenia.
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Introduction
Over the last two decades, several studies have suggested an important bidirectional interaction between psychological stress and the immune system (Glaser and Kiecolt-Glaser, 2005; Kusnecov and Rabin, 1994; Segerstrom and Miller, 2004) . In fact, pro-inflammatory cytokines, such as interleukin 1 (IL-1), IL-6, IL-18 and tumor necrosis factor alpha (TNF-α) are constitutively expressed in different limbic brain regions of the rodent brain (Goshen and Yirmiya, 2009; Pickering et al., 2005; Stellwagen and Malenka, 2006; Tonelli and Postolache, 2005) and the administration of pro-inflammatory cytokines produces a core of endocrine, neurochemical, and behavioral changes that are
